Bio-Rad Laboratories (NYSE:BIO) said yesterday that it inked a definitive agreement to acquire RainDance Technologies for an undisclosed amount. The Hercules, Calif.-based company said it expects the transaction to close in the 1st quarter of 2017 and that it will reveal the terms of the acquisition when it discusses its 4th quarter and full-year financial results for 2016.
Billerica, Mass.-based RainDance Technologies’ intellectual property and product portfolio include technologies to simplify genetic analysis of biological reactions in droplets.
Get the full story at our sister site, Drug Delivery Business News.